ChemoCentryx, Inc. Deferred Revenue (Non-Current)
ChemoCentryx, Inc. had Deferred Revenue (Non-Current) of $57.30 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2022-08-08
- 2022-06-30: Deferred Revenue, Noncurrent $57.30M.
- 2022-03-31: Deferred Revenue, Noncurrent $62.09M.
- 2021-12-31: Deferred Revenue, Noncurrent $24.77M.
- 2021-09-30: Deferred Revenue, Noncurrent $21.42M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2022-06-30 | $57.30M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $62.09M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $24.77M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $21.42M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $24.11M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $23.34M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $24.00M 10-K · filed 2022-03-01 |
| 2020-09-30 | $24.81M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $12.09M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $54.23M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $63.09M 10-K · filed 2021-03-01 |
| 2019-09-30 | $73.89M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $80.17M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $74.45M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $84.10M 10-K · filed 2020-03-10 |
| 2018-09-30 | $92.81M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $93.89M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $74.55M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $72.20M 10-K · filed 2019-03-11 |
| 2017-09-30 | $46.03M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $54.74M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $63.46M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $67.55M 10-K · filed 2018-03-12 |
| 2016-09-30 | $53.08M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $59.66M 10-Q · filed 2016-08-09 |
| 2011-12-31 | $4.54M 10-K · filed 2013-03-14 |